Sanarus Technologies

Sanarus Technologies is a medical device company located in Pleasanton, California, dedicated to minimally invasive breast care solutions. Founded in 2009, the company develops and markets cryotechnology devices aimed at improving the standard of care for breast tumors, particularly in women's health. Their flagship product, the Visica 2 Treatment System, is a cryoablation device that treats benign breast tumors like fibroadenomas, providing a minimally invasive alternative to traditional surgery. The company also offers the Cassi II Rotational Core Biopsy System, an automated device for breast tissue sampling used in diagnostic procedures. Sanarus Technologies focuses on office-based procedures, enhancing convenience and cost-effectiveness for physicians and patients. Their technology is FDA-cleared and has been recognized for its humanitarian applications, contributing to high patient satisfaction rates due to its minimal invasiveness and natural healing benefits. The leadership team, led by CEO BJ Hardman, brings extensive experience in biomedical devices and healthcare management.

• Employees 9
• Founded 2009
• Annual Revenue $84000000
• Total Funding $57120000